Medscape March 9, 2023
Sharon Worcester, MA

The US Food and Drug Administration (FDA) has made changes to existing mammography regulations.

A final rule, updating the regulations issued under the Mammography Quality Standards Act (MQSA) of 1992, requires that mammography facilities notify patients about the density of their breasts, strengthens the FDA’s oversight of facilities, and provides guidance to help physician’s better categorize and assess mammograms, according to a March 9 press release.

The rule requires implementation of the changes within 18 months.

According to the final rule document, the updates are “intended to improve the delivery of mammography services” in ways that reflect changes in mammography technology, quality standards, and the way results are categorized, reported, and communicated to patients and providers.

For instance, mammography reports...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider, Radiology
FDA launches initiative to advance home healthcare models, devices
FDA initiative puts AR/VR at heart of home health drive
Understanding the Value of the Home as a Healthcare Site
FDA approves Lumicell’s breast cancer imaging tool
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases

Share This Article